Top

Breast Cancer Research and Treatment

Published in:

01-04-2011 | Letter to the Editor

Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk

Authors: Bo Xi, Tao Zeng, Weina Liu

Published in: Breast Cancer Research and Treatment | Issue 3/2011

Excerpt

To the Editor, …

Ding H, Fu Y, Chen W, Wang Z (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123:265–270PubMedCrossRef

Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725PubMedCrossRef

Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870–4875PubMed

Bergman-Jungeström M, Wingren S (2001) Catechol-O-methyltransferase (COMT) gene polymorphism and breast cancer risk in young women. Br J Cancer 85:859–862PubMedCrossRef

Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM (2004) A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk. Breast Cancer Res Treat 85:121–131PubMedCrossRef

Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA (2004) Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96:936–945PubMedCrossRef

Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD (2006) Catechol-Omethyltransferase haplotypes and breast cancer among women on Long Island, New York. Breast Cancer Res Treat 99:235–240PubMedCrossRef

The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474CrossRef

Yadav S, Singhal NK, Singh V, Rastogi N, Srivastava PK, Singh MP (2009) Association of single nucleotide polymorphisms in CYP1B1 and COMT genes with breast cancer susceptibility in Indian women. Dis Markers 27:203–210PubMed

10.

Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D (2001) Relationship between the Val108/158Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11:279–286PubMedCrossRef

11.

Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125:837–843PubMedCrossRef

12.

Xi B, Wang C, Wang R, Huang YB (2010) FTO gene polymorphisms are associated with obesity and type 2 diabetes in East Asian populations: an update. Obesity (Silver Spring). doi:10.1038/oby.2010.1139

13.

Sun L, Xi B, Yu L, Gao XC, Shi DJ, Yan YK, Xu DJ, Han Q, Wang C (2010) Association of glutathione S-transferases polymorphisms (GSTM1 and GSTT1) with senile cataract: a meta-analysis. Invest Ophthalmol Vis Sci 51:6381–6386

Xi B, Zeng T, Liu W (2010) Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk. Breast Cancer Res Treat. doi:10.1007/s10549-010-1337-6

Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q (2010) Lack of association betweencatechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725PubMedCrossRef

Ding H, Fu Y, Chen W, Wang Z (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123:265–270PubMedCrossRef

Title: Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk
Authors: Bo Xi
Tao Zeng
Weina Liu
Publication date: 01-04-2011
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2011
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-010-1337-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 3/2011

Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer

Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India

RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway

Bone mineral density and risk of postmenopausal breast cancer

Classification of breast cancer precursors through exhaled breath

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States

Keynote webinar | Spotlight on antibody–drug conjugates in cancer